论文信息 - Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer - 字舞流文

Oncogenic KRAS-associated gene signature defines co-targeting of CDK4/6 and MEK as a viable therapeutic strategy in colorectal cancer

J. Zheng | X. Wu | J. Li | F. Zhang | M. Gong | M. Pek | S. M. Yatim | Q. Yu | Y. Chen | X. Jiang | J. Zheng | M. Pek | Siti Maryam J M Yatim | Yun Chen | Juntao Li | Fan Zhang | Jie Zheng | Xianqiu Wu | Qiang Yu